ZA937592B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA937592B ZA937592B ZA937592A ZA937592A ZA937592B ZA 937592 B ZA937592 B ZA 937592B ZA 937592 A ZA937592 A ZA 937592A ZA 937592 A ZA937592 A ZA 937592A ZA 937592 B ZA937592 B ZA 937592B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929221707A GB9221707D0 (en) | 1992-10-15 | 1992-10-15 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA937592B true ZA937592B (en) | 1994-06-01 |
Family
ID=10723525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA937592A ZA937592B (en) | 1992-10-15 | 1993-10-13 | Pharmaceutical composition |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0664709A1 (en) |
JP (1) | JPH08502281A (en) |
CN (1) | CN1089839A (en) |
AU (1) | AU5154393A (en) |
GB (1) | GB9221707D0 (en) |
WO (1) | WO1994008594A1 (en) |
ZA (1) | ZA937592B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549911A (en) * | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
PT870500E (en) * | 1995-12-22 | 2008-05-07 | Nagase Chemtex Corp | Anti-helicobacter pylori agent |
KR100484328B1 (en) * | 1999-03-17 | 2005-04-20 | 모리나가 세이카 가부시키가이샤 | Foods containing cocoa component |
MXPA05008571A (en) * | 2005-08-12 | 2007-02-12 | Leopoldo Espinosa Abdala | Pharmaceutical formulations in the form of solids, semisolids, in suspension, in solution, in emulsion or in syrup, containing clindamycin and one or more members of the azole family. |
TWI489984B (en) * | 2006-08-04 | 2015-07-01 | Wyeth Corp | Formulations for parenteral delivery of compounds and uses thereof |
JP2011178722A (en) * | 2010-03-01 | 2011-09-15 | Synmosa Biopharma Corp | PHARMACEUTICAL COMPOSITION TO ELIMINATE HELICOBACTER PYLORI (H.pylori) AND METHOD FOR PRODUCING THE SAME |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007325A1 (en) * | 1988-12-30 | 1990-07-12 | Edko Trading And Representation Company Limited | A pessary containing antibacterial drugs |
-
1992
- 1992-10-15 GB GB929221707A patent/GB9221707D0/en active Pending
-
1993
- 1993-10-13 ZA ZA937592A patent/ZA937592B/en unknown
- 1993-10-14 EP EP93922602A patent/EP0664709A1/en not_active Ceased
- 1993-10-14 WO PCT/GB1993/002122 patent/WO1994008594A1/en not_active Application Discontinuation
- 1993-10-14 CN CN93118473A patent/CN1089839A/en active Pending
- 1993-10-14 JP JP6509768A patent/JPH08502281A/en active Pending
- 1993-10-14 AU AU51543/93A patent/AU5154393A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1089839A (en) | 1994-07-27 |
GB9221707D0 (en) | 1992-12-02 |
AU5154393A (en) | 1994-05-09 |
JPH08502281A (en) | 1996-03-12 |
WO1994008594A1 (en) | 1994-04-28 |
EP0664709A1 (en) | 1995-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9224855D0 (en) | Pharmaceutical compositions | |
GB9209078D0 (en) | Pharmaceutical compositions | |
GB9319500D0 (en) | Pharmaceutical composition | |
HUT66864A (en) | Pharmaceutical compositions | |
GB2272375B (en) | Pharmaceutical composition | |
EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
GB9209874D0 (en) | Pharmaceutical compositions | |
CA2100836A1 (en) | Pharmaceutical Composition | |
GB9221707D0 (en) | Pharmaceutical composition | |
ZA935078B (en) | Pharmaceutical composition | |
ZA94155B (en) | Pharmaceutical composition | |
GB9226377D0 (en) | Pharmaceutical compositions | |
ZA935931B (en) | Pharmaceutical composition | |
ZA924061B (en) | Pharmaceutical composition | |
GB9211276D0 (en) | Pharmaceutical compositions | |
ZA931984B (en) | Pharmaceutical composition | |
GB9216600D0 (en) | Pharmaceutical composition | |
GB9204472D0 (en) | Pharmaceutical composition | |
GB9225170D0 (en) | Pharmaceutical composition | |
GB9225159D0 (en) | Pharmaceutical composition | |
GB9221003D0 (en) | Pharmaceutical composition | |
ZA931863B (en) | Pharmaceutical composition | |
GB9203248D0 (en) | Pharmaceutical composition | |
GB9213042D0 (en) | Pharmaceutical composition | |
GB9203897D0 (en) | Pharmaceutical composition |